Results 281 to 290 of about 8,713,756 (356)
Early CD4+ T cell proliferation and chronic T cell engagement impact myeloma outcomes following T cell engager therapy. [PDF]
Duffy AM +14 more
europepmc +1 more source
Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son +13 more
wiley +1 more source
Regulatory T cell approaches for graft-versus-host disease prevention. [PDF]
Bader CS, Meyer EH, Negrin RS.
europepmc +1 more source
Editorial: Enhancing CAR T-cell therapy with imaging. [PDF]
Lopci E, de Jong D, Dercle L.
europepmc +1 more source
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance. [PDF]
Ponzo M +23 more
europepmc +1 more source
Proteasome: Role in T Cell Function Regulation. [PDF]
Tang D, Wu X, Lei JH, Qiao Y, Deng CX.
europepmc +1 more source

